Literature DB >> 12813806

Survey of the late consequences of polio in Edinburgh and the Lothians.

B Pentland1, D Hellawell, J Benjamin, R Prasad, A Ainslie.   

Abstract

OBJECTIVE: This study aimed to identify the nature and frequency of new symptoms and associated disabilities experienced by people who suffered poliomyelitis many years ago, and their access to hospital services.
DESIGN: Postal survey regarding symptoms, disability (Office of Population Censuses & Surveys (OPCS) disability questionnaire), and experience of services. SUBJECTS &
SETTING: People known to the British Polio Fellowship and the regional rehabilitation service who had previously had polio and were resident in Edinburgh and the Lothians.
RESULTS: The study population of 125 people had a median age of 59 years, and 60% were female. The most common symptoms, present in over 60%, were: cold intolerance, fatigue, increased and new muscle weakness, muscle and joint pain, and sleep disturbance. Motor disabilities, particularly of lower limbs, were prominent. Patient contact with hospital services in the preceding five years was: clinic (62%); physiotherapy (46%); occupational therapy (29%); speech therapy (2%); wheelchair service (42%); orthotics (40%).
CONCLUSIONS: New problems are sufficiently frequent and severe to warrant a more detailed study to quantify the health care requirements of the post-polio population.

Entities:  

Mesh:

Year:  2000        PMID: 12813806

Source DB:  PubMed          Journal:  Health Bull (Edinb)        ISSN: 0374-8014


  2 in total

1.  Update on current and emerging treatment options for post-polio syndrome.

Authors:  Elisabeth Farbu
Journal:  Ther Clin Risk Manag       Date:  2010-07-21       Impact factor: 2.423

2.  Postpolio Syndrome: A Review of Lived Experiences of Patients.

Authors:  Oluwaseyi Jacob Oluwasanmi; Devaunna Andrene Mckenzie; Idowu Oluwasegun Adewole; Christian O Aluka; James Iyasse; Esther Olunu; Adegbenro Omotuyi Fakoya
Journal:  Int J Appl Basic Med Res       Date:  2019 Jul-Sep
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.